DTIL: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	11M	13,000	18,000	29,000	576,000	50M
Research and development	13M	13M	13M	14M	13M	17M
Selling, general and administrative	7M	7M	9M	9M	9M	9M
Operating expenses	20M	21M	22M	22M	22M	26M
Operating income	−9M	−21M	−22M	−22M	−21M	24M
Interest expense	—	—	—	354,000	256,000	560,000
Net income	−18M	−22M	−24M	−21M	−16M	33M
Earnings per share	−0.75	−1.84	−2.13	−2.21	−2.25	4.70
Earnings per share, diluted	−0.75	−1.84	−2.13	−2.21	−2.25	4.67
Weighted average shares	25M	12M	11M	9M	7M	7M
Weighted average shares, diluted	25M	12M	11M	9M	7M	7M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	99M	111M	45M	62M	77M	86M	99M	124M
Short-term investments	2M	5M	0	0	—	413,000	2M	—
Receivables	4M	0	4,000	0	4,000	229,000	188,000	207,000
Current assets	109M	119M	52M	70M	82M	95M	111M	144M
Property, plant and equipment	1M	1M	2M	2M	3M	3M	4M	4M
Total assets	144M	154M	94M	109M	124M	136M	153M	166M
Current liabilities	8M	9M	15M	14M	12M	15M	12M	33M
Total liabilities	68M	62M	77M	75M	75M	80M	88M	91M
Equity	76M	92M	17M	34M	49M	56M	65M	75M
Shares outstanding	26M	24M	12M	12M	11M	8M	7M	7M
Shares issued	26M	24M	12M	12M	11M	8M	8M	7M

Metric	31/03/2026	31/03/2025
Operating cash flow	−12M	−19M
Depreciation and amortisation	299,000	395,000
Share-based compensation	2M	3M
Capital expenditure	18,000	64,000
Investing cash flow	−114,000	−314,000
Financing cash flow	745,000	11M